1.5095
price down icon2.61%   -0.0405
 
loading
Adlai Nortye Ltd Adr stock is traded at $1.5095, with a volume of 2,673. It is down -2.61% in the last 24 hours and up +7.81% over the past month. Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
See More
Previous Close:
$1.55
Open:
$1.55
24h Volume:
2,673
Relative Volume:
0.17
Market Cap:
$46.86M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-0.5991
EPS:
-2.5197
Net Cash Flow:
-
1W Performance:
-0.03%
1M Performance:
+7.81%
6M Performance:
-26.37%
1Y Performance:
-57.24%
1-Day Range:
Value
$1.50
$1.55
1-Week Range:
Value
$1.50
$1.5506
52-Week Range:
Value
$1.10
$3.89

Adlai Nortye Ltd Adr Stock (ANL) Company Profile

Name
Name
Adlai Nortye Ltd Adr
Name
Phone
-
Name
Address
-
Name
Employee
123
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
ANL's Discussions on Twitter

Compare ANL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ANL
Adlai Nortye Ltd Adr
1.50 57.93M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.48 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.42 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.11 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
574.22 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.44 29.19B 3.81B -644.79M -669.77M -6.24

Adlai Nortye Ltd Adr Stock (ANL) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-02-25 Downgrade H.C. Wainwright Buy → Neutral
Sep-04-24 Initiated H.C. Wainwright Buy
Oct-24-23 Initiated Cantor Fitzgerald Overweight

Adlai Nortye Ltd Adr Stock (ANL) Latest News

pulisher
Jul 09, 2025

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Esperion (ESPR) - The Globe and Mail

Jul 09, 2025
pulisher
Jul 09, 2025

Adlai Nortye Ltd. Announces 2025 Share Incentive Plan and Board Changes - TipRanks

Jul 09, 2025
pulisher
Jul 06, 2025

Analysts Offer Insights on Healthcare Companies: NextCure (NXTC), Lexaria Bioscience (LEXX) and Travere Therapeutics (TVTX) - The Globe and Mail

Jul 06, 2025
pulisher
Jun 27, 2025

Adlai Nortye (NASDAQ:ANL) Trading Down 5.5% – Here’s What Happened - Defense World

Jun 27, 2025
pulisher
Jun 24, 2025

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Capricor Therapeutics (CAPR) and Abbott Laboratories (ABT) - The Globe and Mail

Jun 24, 2025
pulisher
Jun 02, 2025

H.C. WAINWRIGHT CUTS ADLAI NORTYE STOCK RATING AFTER TRIAL RESULTS By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

H.C. WAINWRIGHT CUTS ADLAI NORTYE STOCK RATING AFTER TRIAL RESULTS - Investing.com

Jun 02, 2025
pulisher
May 30, 2025

Adlai Nortye Discontinues Buparlisib Development After Phase III Trial Results - TipRanks

May 30, 2025
pulisher
Apr 17, 2025

ANL stock touches 52-week low at $1.71 amid sharp annual decline - Investing.com India

Apr 17, 2025
pulisher
Apr 17, 2025

ANL stock touches 52-week low at $1.71 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 17, 2025
pulisher
Apr 07, 2025

ANL stock touches 52-week low at $1.85 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

ANL stock touches 52-week low at $1.85 amid sharp annual decline - Investing.com India

Apr 07, 2025
pulisher
Mar 28, 2025

Adlai Nortye stock hits 52-week low at $1.85 amid sharp decline By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Adlai Nortye stock hits 52-week low at $1.85 amid sharp decline - Investing.com India

Mar 28, 2025
pulisher
Feb 14, 2025

Adlai Nortye Announces Change in Auditing Firm - TipRanks

Feb 14, 2025
pulisher
Dec 31, 2024

Adlai Nortye Announces CFO Transition with Interim Appointment - TipRanks

Dec 31, 2024
pulisher
Oct 18, 2024

Adlai Nortye stock strengthened by oncology trial results, H.C. Wainwright keeps at Buy list - Investing.com India

Oct 18, 2024
pulisher
Sep 29, 2023

Adlai Nortye IPO gives old Novartis cancer drug new life - BioPharma Dive

Sep 29, 2023
pulisher
Sep 27, 2023

Adlai Nortye Announces 2.5M ADS IPO at $23/sh - Investing.com

Sep 27, 2023
pulisher
Aug 17, 2023

CRVO Stock Quote Price and Forecast - CNN

Aug 17, 2023

Adlai Nortye Ltd Adr Stock (ANL) Financials Data

There is no financial data for Adlai Nortye Ltd Adr (ANL). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$22.84
price up icon 4.74%
$36.04
price down icon 0.14%
$102.98
price down icon 0.01%
$27.88
price up icon 5.03%
$113.83
price up icon 2.13%
biotechnology ONC
$294.48
price down icon 0.29%
Cap:     |  Volume (24h):